JP2017502253A5 - - Google Patents

Download PDF

Info

Publication number
JP2017502253A5
JP2017502253A5 JP2016521777A JP2016521777A JP2017502253A5 JP 2017502253 A5 JP2017502253 A5 JP 2017502253A5 JP 2016521777 A JP2016521777 A JP 2016521777A JP 2016521777 A JP2016521777 A JP 2016521777A JP 2017502253 A5 JP2017502253 A5 JP 2017502253A5
Authority
JP
Japan
Prior art keywords
antibody
ibs
vinculin
cdt
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016521777A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017502253A (ja
JP6567509B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/059957 external-priority patent/WO2015054529A1/en
Publication of JP2017502253A publication Critical patent/JP2017502253A/ja
Publication of JP2017502253A5 publication Critical patent/JP2017502253A5/ja
Application granted granted Critical
Publication of JP6567509B2 publication Critical patent/JP6567509B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016521777A 2013-10-09 2014-10-09 過敏性腸症候および炎症性腸疾患の診断および治療 Active JP6567509B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361888658P 2013-10-09 2013-10-09
US61/888,658 2013-10-09
PCT/US2014/059957 WO2015054529A1 (en) 2013-10-09 2014-10-09 Diagnosis and treatment of irritable bowel syndrome and inflammatory bowel disease

Publications (3)

Publication Number Publication Date
JP2017502253A JP2017502253A (ja) 2017-01-19
JP2017502253A5 true JP2017502253A5 (enExample) 2017-11-16
JP6567509B2 JP6567509B2 (ja) 2019-08-28

Family

ID=52813648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016521777A Active JP6567509B2 (ja) 2013-10-09 2014-10-09 過敏性腸症候および炎症性腸疾患の診断および治療

Country Status (19)

Country Link
US (2) US9851361B2 (enExample)
EP (1) EP3054977B1 (enExample)
JP (1) JP6567509B2 (enExample)
KR (1) KR102259588B1 (enExample)
CN (1) CN105744956B (enExample)
AU (2) AU2014331841B2 (enExample)
BR (1) BR112016007474A2 (enExample)
CA (1) CA2923651C (enExample)
CL (1) CL2016000820A1 (enExample)
ES (1) ES2892905T3 (enExample)
IL (1) IL244971B2 (enExample)
MX (1) MX383423B (enExample)
NZ (1) NZ717633A (enExample)
PE (1) PE20160882A1 (enExample)
PL (1) PL3054977T3 (enExample)
PT (1) PT3054977T (enExample)
RU (1) RU2683781C2 (enExample)
SG (1) SG11201601733VA (enExample)
WO (1) WO2015054529A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2656850T3 (es) 2009-02-11 2018-02-28 Cedars-Sinai Medical Center Diagnóstico del síndrome intestinal inflamatorio con base en la toxina de distensión citoletal
US11693009B2 (en) 2009-02-11 2023-07-04 Cedars-Sinai Medical Center Methods for detecting post-infectious irritable bowel syndrome
AU2013315981B2 (en) 2012-09-17 2019-04-18 Cedars-Sinai Medical Center Diagnosis and treatment of motility disorders of the gut and bladder, and of fibromyalgia
RU2683781C2 (ru) 2013-10-09 2019-04-02 Седарс-Синаи Медикал Сентер Диагностика и лечение синдрома раздраженного кишечника и воспалительного заболевания кишечника
NZ730490A (en) 2014-10-09 2021-07-30 Cedars Sinai Medical Center Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
CN106053827A (zh) * 2016-05-17 2016-10-26 上海凯璟生物科技有限公司 一种肠易激综合症标志物Vinculin抗体检测试剂盒及其制备方法
CN105784989A (zh) * 2016-05-17 2016-07-20 上海凯璟生物科技有限公司 一种肠易激综合症标志物CdtB抗体检测试剂盒及其制备方法
EP3458466B1 (en) * 2016-05-20 2024-08-07 Cedars-Sinai Medical Center Diagnosis of inflammatory bowel disease based on genes
EP3573650A4 (en) 2017-01-30 2020-12-09 Cedars-Sinai Medical Center DIAGNOSIS OF SCLERODERMIA
RU2763258C1 (ru) * 2020-07-13 2021-12-28 Евгения Николаевна Воронина Способ дифференциальной диагностики воспалительных заболеваний кишечника у детей по комплексу клинико-анамнестических, лабораторных и инструментальных критериев

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691151A (en) * 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6562629B1 (en) 1999-08-11 2003-05-13 Cedars-Sinai Medical Center Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum
FR2806805A1 (fr) 2000-03-22 2001-09-28 Centre Nat Rech Scient SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS
WO2003097854A2 (en) 2002-05-17 2003-11-27 Sugen, Inc. Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals
US20070010434A1 (en) 2002-09-16 2007-01-11 Genetech, Inc. Novel compositions and methods for the treatment of immune related diseases
US7595386B2 (en) 2003-01-24 2009-09-29 William Beaumont Hospital Methods and compositions for heat activated gene therapy using cytolethal distending toxin
MXPA05010819A (es) * 2003-04-08 2006-03-30 Progenics Pharm Inc Uso de antagonistas de opioide perifericos, especialmente metilnaltrexona para tratar sindrome de intestino irritable.
ATE491953T1 (de) * 2003-09-15 2011-01-15 Oklahoma Med Res Found Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
WO2005054472A1 (ja) 2003-12-05 2005-06-16 Fuso Pharmaceutical Industries, Ltd. 細胞膨張化致死毒およびそれを標的としたカンピロバクター属に属する細菌の検出
EP2102367A2 (en) 2006-11-09 2009-09-23 XDX, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
DK2223121T3 (da) 2007-12-20 2012-10-22 Index Diagnostics Ab Publ Fremgangsmåde og kit til anvendelse ved differentiering mellem ibd og ibs og yderligere skelnen mellem ibd-sygdomstyper
ES2529060T3 (es) 2008-11-24 2015-02-16 Cedars-Sinai Medical Center Derivados antioxidantes de la camptotecina y nanoesferas antineoplásicas antioxidantes de los mismos
WO2010093776A1 (en) 2009-02-11 2010-08-19 Cedars-Sinai Medical Center Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
ES2656850T3 (es) * 2009-02-11 2018-02-28 Cedars-Sinai Medical Center Diagnóstico del síndrome intestinal inflamatorio con base en la toxina de distensión citoletal
FR2942541A1 (fr) 2009-02-25 2010-08-27 Assist Publ Hopitaux De Paris Procede de diagnostic d'une vascularite
RU2397178C1 (ru) * 2009-02-27 2010-08-20 Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека Диагностическая тест-система в формате иммуночипа и способ серологической дифференциальной диагностики сифилиса
IT1400989B1 (it) 2010-07-13 2013-07-05 Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale.
GB201017520D0 (en) 2010-10-15 2010-12-01 Sense Proteomic Ltd Biomarkers
AU2013315981B2 (en) 2012-09-17 2019-04-18 Cedars-Sinai Medical Center Diagnosis and treatment of motility disorders of the gut and bladder, and of fibromyalgia
RU2683781C2 (ru) 2013-10-09 2019-04-02 Седарс-Синаи Медикал Сентер Диагностика и лечение синдрома раздраженного кишечника и воспалительного заболевания кишечника
NZ730490A (en) 2014-10-09 2021-07-30 Cedars Sinai Medical Center Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease
CN106091069A (zh) 2016-06-15 2016-11-09 安徽省绿巨人环境技术有限公司 一种废水再利用装置
EP3573650A4 (en) 2017-01-30 2020-12-09 Cedars-Sinai Medical Center DIAGNOSIS OF SCLERODERMIA

Similar Documents

Publication Publication Date Title
JP2017502253A5 (enExample)
JP7022969B2 (ja) SARS-CoV-2感染症を診断するための方法および試薬
Lee Procalcitonin as a biomarker of infectious diseases
JP2010514805A5 (enExample)
RU2016116766A (ru) Диагностика и лечение синдрома раздраженного кишечника и воспалительного заболевания кишечника
JP2017524130A5 (enExample)
CN102395887A (zh) 用于检测降钙素原的免疫测定法
DK2904403T3 (en) PROCEDURE FOR DIAGNOSTICATION OR MONITORING OF Kidney Function or Diagnosis of Kidney Function
US20130296240A1 (en) Pneumonia biomarkers
JP2018524585A (ja) Pla2r1エピトーププロファイルおよびpla2r1エピトープスプレッディングの分析に基づく膜性腎症の予後およびモニタリング
US11598772B2 (en) Method and products for the diagnosis of a seafood allergy
Guihot et al. Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A (H1N1) 2009 infection
JP2017531801A5 (enExample)
TW201231670A (en) A kit for examining plasma or serum antibody titers against periodontal pathogens
JP2018515071A5 (enExample)
JP6609570B2 (ja) がんを検出するための方法およびバイオマーカー
Bomze et al. Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
ES2793001T3 (es) Marcadores diagnósticos de inmunosenescencia y métodos para determinar la susceptibilidad a las infecciones nosocomiales
JP2011516037A5 (enExample)
US9068993B2 (en) Diagnostic assays and methods of use for detection of filarial infection
CN104937419B (zh) 预测受试者患癌症的风险或诊断癌症的方法
CN113366012A (zh) 幽门螺杆菌菌株的鉴定方法及鉴定试剂盒
KR102128251B1 (ko) 아르기닌이 메틸화된 drd2에 특이적으로 결합하는 대장암 진단용 바이오마커 조성물
WO2019135477A3 (ko) 다복제유전자를 이용한 쯔쯔가무시병의 진단방법
IL295754A (en) Methods and reagents for the diagnosis of sars-cov-2 infection